These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4003989)

  • 1. Danazol therapy in myelodysplasia.
    Cines DB; Cassileth PA; Kiss JE
    Ann Intern Med; 1985 Jul; 103(1):58-60. PubMed ID: 4003989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus.
    West SG; Johnson SC
    Ann Intern Med; 1988 May; 108(5):703-6. PubMed ID: 3358571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danazol for the treatment of idiopathic thrombocytopenic purpura.
    Ahn YS; Harrington WJ; Simon SR; Mylvaganam R; Pall LM; So AG
    N Engl J Med; 1983 Jun; 308(23):1396-9. PubMed ID: 6682484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of danazol for treatment of corticosteroid-resistant immune-mediated thrombocytopenia in a dog.
    Bloom JC; Meunier LD; Thiem PA; Sellers TS
    J Am Vet Med Assoc; 1989 Jan; 194(1):76-8. PubMed ID: 2914797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of vincristine-loaded blood platelets, danazol and gamma globulin in the treatment of patients with idiopathic thrombocytopenic purpura].
    Górski J; Czestochowska E; Tymiński W; Kicińska M
    Acta Haematol Pol; 1989; 20(1):65-71. PubMed ID: 2618568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of danazol in the management of chronic idiopathic thrombocytopenic purpura.
    Heyd J; Hershko C
    Isr J Med Sci; 1985 May; 21(5):418-20. PubMed ID: 4040506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women.
    Ahn YS; Rocha R; Mylvaganam R; Garcia R; Duncan R; Harrington WJ
    Ann Intern Med; 1989 Nov; 111(9):723-9. PubMed ID: 2802430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.
    Bourgeois E; Caulier MT; Rose C; Dupriez B; Bauters F; Fenaux P
    Leukemia; 2001 Jun; 15(6):950-3. PubMed ID: 11417482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of danazol in immune thrombocytopenic purpura.
    Schreiber AD; Chien P; Tomaski A; Cines DB
    N Engl J Med; 1987 Feb; 316(9):503-8. PubMed ID: 3807993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danazol for lupus thrombocytopenia.
    Marino C; Cook P
    Arch Intern Med; 1985 Dec; 145(12):2251-2. PubMed ID: 4074040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol therapy in refractory chronic immune thrombocytopenic purpura.
    Mazzucconi MG; Francesconi M; Falcione E; Ferrari A; Gandolfo GM; Ghirardini A; Tirindelli MC
    Acta Haematol; 1987; 77(1):45-7. PubMed ID: 3107321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danazol treatment of myelodysplastic syndromes.
    Stadtmauer EA; Cassileth PA; Edelstein M; Abrahm J; Schreiber AD; Nowell PC; Cines DB
    Br J Haematol; 1991 Apr; 77(4):502-8. PubMed ID: 1827346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol therapy for cyclic thrombocytopenia.
    Rocha R; Horstman L; Ahn YS; Mylvaganam R; Harrington WJ
    Am J Hematol; 1991 Feb; 36(2):140-3. PubMed ID: 2012064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy.
    Hebbar M; Kaplan C; Caulier MT; Wattel E; Morel P; Wetterwald M; Bauters F; Fenaux P
    Br J Haematol; 1996 Jul; 94(1):112-5. PubMed ID: 8757517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Danazol in refractory autoimmune thrombocytopenic purpura (ATP). A new therapeutic sequence.
    Ambriz-Fernández R; Chávez-Sánchez G; Pizzuto-Chávez J; Morales-Polanco MR; Aviles-Miranda A
    Arch Invest Med (Mex); 1985; 16(3):295-304. PubMed ID: 3833096
    [No Abstract]   [Full Text] [Related]  

  • 16. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy.
    Kondo H; Iseki T; Goto S; Takaso T; Ohto M; Okuda K
    Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danazol for the treatment of idiopathic thrombocytopenic purpura.
    Buelli M; Cortelazzo S; Viero P; Minetti B; Comotti B; Bassan R; Barbui T
    Acta Haematol; 1985; 74(2):97-8. PubMed ID: 3937423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danazol in acquired amegakaryocytic thrombocytopenic purpura: a case report.
    Kayser W; Euler HH; Schmitz N; Gassmann W; Löffler H; Asbeck F
    Blut; 1985 Dec; 51(6):401-4. PubMed ID: 3852685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome.
    Chan G; DiVenuti G; Miller K
    Am J Hematol; 2002 Nov; 71(3):166-71. PubMed ID: 12410570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of danazol in the management of chronic immune thrombocytopenic purpura.
    McVerry BA; Auger M; Bellingham AJ
    Br J Haematol; 1985 Sep; 61(1):145-8. PubMed ID: 4052322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.